Xi'an Bohua Pharmaceutical

Xi'an Bohua Pharmaceutical, a subsidiary of Huadong Medicine, is a Chinese pharmaceutical company established in 1998 that specializes in the development and production of chemical raw materials (APIs) and finished dosage forms. The company operates GMP-certified facilities in Shaanxi province, producing a wide range of products including anti-infectives, cardiovascular medications, and digestive system treatments. Its portfolio features notable products such as ornidazole, omeprazole, and domperidone, as well as newer additions like olaparib and brexpiprazole. Xi'an Bohua serves both domestic and international markets, leveraging its research and development center to advance its pipeline of generic and innovative drugs.